Search results for "Risk Reduction Behavior*"

showing 10 items of 58 documents

Education and hypertension: impact on global cardiovascular risk

2017

Background: Improving cardiovascular risk prediction continues to be a major challenge and effective prevention of cardiovascular disease. Accordingly, several studies have recently reported on the role of cardiovascular risk education. This study was designed to evaluate the impact of education on global cardiovascular risk in hypertensive patients.Subjects and methods: The study population consisted of 223 consecutive hypertensive outpatients. Their educational status was categorized according to the number of years of formal education as follows: (1) low education (less than 10 years) and (2) medium-high education (10-15 years).Results: In both groups, cardiometabolic comorbidities, glob…

AdultMalemedicine.medical_specialtyhypertensionLow educationComorbidityDisease030204 cardiovascular system & hematologyBody Mass IndexEducation03 medical and health sciences0302 clinical medicineRisk FactorsFormal educationPrevalenceAlbuminuriaHumansMedicine030212 general & internal medicineglobal cardiovascular riskAntihypertensive AgentsMetabolic SyndromeWaist-Hip Ratiobusiness.industryBlood Pressure DeterminationGeneral MedicineMiddle Agedmedicine.diseaseCross-Sectional StudiesItalyCardiovascular DiseasesEchocardiographyEmergency medicinePhysical therapyEducational StatusPopulation studyFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessRisk Reduction BehaviorActa Cardiologica
researchProduct

The role of personality disorders on drug dependence treatment outcomes following inpatient detoxification

2004

AbstractAimsThe present 6 month follow-up study was conducted to investigate the possible influence of comorbid personality disorders on drug treatment, as well as associated psychopathology and HIV-related risk behaviors outcomes.Subjects and methodsData were collected initially from a consecutive sample of 74 patients with a diagnosis of opiate abuse or dependence, admitted for inpatient detoxification.ResultDuring intake, 80.9% of patients reported at least one HIV-related risk behavior in the previous 6 months. Not using condoms during sexual intercourse was the most common and the only risk behavior that showed a statistically significant reduction over the follow-up period. A total of…

AdultMalemedicine.medical_specialtymedia_common.quotation_subjectPsychological interventionHIV InfectionsComorbidityPersonality Disorders03 medical and health sciencesRisk-Taking0302 clinical medicineAcquired immunodeficiency syndrome (AIDS)medicineHumansPersonalityPsychiatrymedia_commonAddictionOpioid-Related Disordersmedicine.diseasePersonality disorders030227 psychiatryHospitalizationPsychiatry and Mental healthSexual intercourseTreatment OutcomeFemaleOpiatePsychologyRisk Reduction Behavior030217 neurology & neurosurgeryFollow-Up StudiesPsychopathologyEuropean Psychiatry
researchProduct

Cardiovascular Benefits of Group Sport Interventions: Importance of Improved Fitness in Risk Reduction

2018

BACKGROUND: Physical inactivity is a leading risk factor for cardiovascular disease worldwide. Group sport participation offers a unique, engaging approach for delivering physical activity interventions, but its overall effect on cardiometabolic risk factors is unclear. OBJECTIVE: To estimate the pooled effects of community-based, recreational-level group sports on cardiometabolic risk factors and fitness parameters among adults. METHODS AND RESULTS: We systematically searched electronic databases for English articles reporting the effectiveness of recreational-level group sports, published between January 1, 1965 and January 17, 2017. We extracted baseline and end of intervention means for…

Adultmedicine.medical_specialtyPsychological interventiongroup sportliikunta030204 cardiovascular system & hematologyArticleReduction (complexity)03 medical and health sciences0302 clinical medicinemedicineHumansExerciseinterventionsinterventiorisk reductionbusiness.industryta3142riskitekijät030229 sport sciencesGeneral MedicinebenefitsfitnessCardiovascular Diseasessydän- ja verisuonitauditcardiovascular systemPhysical therapybusinessRisk Reduction BehaviorSportsMayo Clinic Proceedings
researchProduct

Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?

2018

For some time, it has been assumed that women with polycystic ovary syndrome (PCOS) are at increased risk of developing cardiovascular disease (CVD). This has largely been on the basis of having many risk factors, including abnormal lipid profile, insulin resistance, and markers of inflammation. However, despite having these and other risk factors, we argue here, in the view of the authors, that there is no credible evidence that there is greater CVD morbidity in all women with PCOS. We analyze the existing data and discuss that overall CVD risk decreases with age when more CVD events are likely to occur, and introduce the possibility that there may be some unknown inherent protective facto…

Adultmedicine.medical_specialtyendocrine system diseasesProtective factor030209 endocrinology & metabolismDiseaseRisk Assessment03 medical and health sciences0302 clinical medicineInsulin resistanceRisk FactorsDiabetes mellitusmedicineDiabetes MellitusHumansObesityMenstruation Disturbances030219 obstetrics & reproductive medicinebusiness.industryObstetricsHyperandrogenismAbsolute risk reductionnutritional and metabolic diseasesGeneral Medicinemedicine.diseasePolycystic ovaryObesityfemale genital diseases and pregnancy complicationsCardiovascular DiseasesFemalebusinessHyperandrogenismRisk Reduction BehaviorPolycystic Ovary SyndromeJournal of women's health (2002)
researchProduct

The Paradigm of Life Extension

2010

AgingSettore MED/09 - Medicina InternaHuman Growth HormoneLife stylebusiness.industryHealth PolicyGeneral Medicineaging life style chronic diseases disability antiagingLife extensionLife ExpectancyHumansMedicineGeriatrics and GerontologybusinessRisk Reduction BehaviorGeneral NursingCaloric RestrictionStem Cell TransplantationCognitive psychologyJournal of the American Medical Directors Association
researchProduct

What are the roles of calorie restriction and diet quality in promoting healthy longevity?

2014

Epidemiological and experimental data indicate that diet plays a central role in the pathogenesis of many age-associated chronic diseases, and in the biology of aging itself. Data from several animal studies suggest that the degree and time of calorie restriction (CR) onset, the timing of food intake as well as diet composition, play major roles in promoting health and longevity, breaking the old dogma that only calorie intake is important in extending healthy lifespan. Data from human studies indicate that long-term CR with adequate intake of nutrients results in several metabolic adaptations that reduce the risk of developing type 2 diabetes, hypertension, cardiovascular disease and cance…

Agingmedicine.medical_specialtyDisease preventionTime Factorsmedia_common.quotation_subjectLongevityCalorie restrictionNutritional StatusPhysiologyType 2 diabetesDiseaseBiologyVegetarian dietBiochemistryCalorie restriction Diet quality Health Lifespan Vegetarian diet Disease preventionLife ExpectancyNutrientNeoplasmsInternal medicinemedicineAnimalsHumansLife StyleMolecular BiologyCalorie restrictionCaloric Restrictionmedia_common2. Zero hungerLifespanAge FactorsLongevityCalorie restriction; Diet quality; Disease prevention; Health; Lifespan; Vegetarian diet; Age Factors; Aging; Animals; Cardiovascular Diseases; Energy Metabolism; Humans; Longevity; Neoplasms; Nutritional Status; Time Factors; Caloric Restriction; Diet; Life Expectancy; Life Style; Risk Reduction BehaviorVegan Dietmedicine.diseaseDiet3. Good healthEndocrinologyNeurologyHealthCardiovascular DiseasesDietary Reference IntakeAnimal studiesEnergy MetabolismRisk Reduction BehaviorDiet qualityBiotechnology
researchProduct

Factorial structure of recklessness: To what extent are older drivers different?

2003

This study tests whether the original factorial structure of a recklessness questionnaire can be maintained for the current Spanish population of older drivers.Our recent interest in dedicating special attention to senior citizen mobility (Monterde, 2001), is due to the impending increase of the aging population in Western countries; this has led us to reinitiate the psychometric study of the construct validity, revising and including older drivers in the psychometric aspects of those evaluation instruments that will then be used in the Spanish psycho-medical check of drivers and in research.Factorial analysis was used to determine validity.There was an appearance of a different psychologic…

Automobile DrivingEngineeringPopulation ageingPsychometricsApplied psychologyPoison controlAffect (psychology)Computer securitycomputer.software_genreTraffic psychologySurveys and QuestionnairesInjury preventionHumansPsychological testingSafety Risk Reliability and QualityAgedbusiness.industryAccidents TrafficAge FactorsConstruct validityAttitudeGeriatricsSafetyRecklessnessbusinessRisk Reduction BehaviorcomputerJournal of Safety Research
researchProduct

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-…

2017

Background: \ud Liraglutide 3·0 mg was shown to reduce bodyweight and improve glucose metabolism after the 56-week period of this trial, one of four trials in the SCALE programme. In the 3-year assessment of the SCALE Obesity and Prediabetes trial we aimed to evaluate the proportion of individuals with prediabetes who were diagnosed with type 2 diabetes.\ud \ud Methods: \ud In this randomised, double-blind, placebo-controlled trial, adults with prediabetes and a body-mass index of at least 30 kg/m2, or at least 27 kg/m2 with comorbidities, were randomised 2:1, using a telephone or web-based system, to once-daily subcutaneous liraglutide 3·0 mg or matched placebo, as an adjunct to a reduced-…

Blood GlucoseMaleEXENATIDEType 2 diabetes030204 cardiovascular system & hematologyBody Mass Indexlaw.inventionPlacebosImpaired glucose toleranceMELLITUS3.0 MG0302 clinical medicineRandomized controlled trialGlucagon-Like Peptide 1lawPREVENTION PROGRAM OUTCOMESPrediabetesPREVENTION PROGRAM OUTCOMES; IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE; CLINICAL-TRIAL; OBESE SUBJECTS; 3.0 MG; REGRESSION; EXENATIDE; MELLITUSSubcutaneousMedicine (all)General MedicineMiddle AgedAdult; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus Type 2; Double-Blind Method; Female; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Incretins; Injections Subcutaneous; Liraglutide; Male; Middle Aged; Obesity; Placebos; Prediabetic State; Risk Reduction Behavior; Treatment Outcome; Weight Loss3. Good healthTreatment OutcomeFemaleLIFE-STYLEType 2OBESE SUBJECTSmedicine.drugAdultmedicine.medical_specialtyInjections Subcutaneous030209 endocrinology & metabolismPlaceboIncretinsGlucagon-Like Peptide-1 ReceptorInjectionsCLINICAL-TRIALPrediabetic State03 medical and health sciencesIMPAIRED GLUCOSE-TOLERANCEDouble-Blind MethodDiabetes mellitusInternal medicineWeight LossREGRESSIONDiabetes MellitusmedicineHumansHypoglycemic AgentsObesityLiraglutidebusiness.industryBody WeightLiraglutidemedicine.diseaseClinical trialEndocrinologyDiabetes Mellitus Type 2Human medicinebusinessRisk Reduction Behavior[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyThe Lancet
researchProduct

Consensus Document on Intermittent Claudication from the Central European Vascular Forum (C.E.V.F.)-3rd revision (2013) with the sharing of the Medit…

2014

This paper is the review of the Consensus Document on Intermittent Claudication of the Central European Vascular Forum (CEVF), published in 2008, and and shared with the North Africa and Middle East Chapter of International Union of Angiology and the Mediterranean League of Angiology and Vascular Surgery. The Document presents suggestions for general practitioners and vascular specialists for more precise and appropriate management of PAD, particularly of intermittent claudication, and underlines the investigations that should be required by GPs and what the GP should expect from the vascular specialist (angiologist, vascular surgeon). The idea of the Faculty is to produce a short document,…

ConsensusCritical IllnessGeneral Practiceintermittent claudicatioCardiovascular AgentsIntermittent ClaudicationSettore MED/11 - Malattie Dell'Apparato CardiovascolareSeverity of Illness IndexPeripheral Arterial DiseaseTreatment OutcomeIschemiaRisk FactorsAsymptomatic DiseasesHumansconsensus; intermittent claudicatio; peripheral arterial diseaseReferral and ConsultationRisk Reduction BehaviorVascular Surgical ProceduresIntermittent claudication peripheral arterial disease disease managementInternational angiology : a journal of the International Union of Angiology
researchProduct

Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper

2018

Current evidence shows that cholesterol management either reduces the likelihood of cardiovascular disease (CVD) or slows down its progression. Hence, it is important that all health professionals make appropriate use of all the available intervention strategies to control risk factors: from dietary improvement and positive lifestyle changes to the use of functional foods, food supplements, and drugs. This review examines the effect of the most frequently occurring cholesterol-lowering substances in functional foods or in supplements across Europe, namely plant sterols and stanols, monacolin K found in red yeast rice, berberine and beta-glucans. We conclude that currently available suppleme…

ConsensusFunctional foodsClinical Decision-MakingFood supplementDisease030204 cardiovascular system & hematologyLDL03 medical and health scienceschemistry.chemical_compound0302 clinical medicineNutraceuticalPlasma cholesterolRisk FactorsEnvironmental healthFood supplementsRed yeast riceMedicineAnimalsHumans030212 general & internal medicineCardiovascular risk; Cholesterol; Food supplements; Functional foods; LDL cholesterol; Primary prevention; Animals; Biomarkers; Cardiovascular Diseases; Cholesterol LDL; Clinical Decision-Making; Consensus; Dyslipidemias; Evidence-Based Medicine; Humans; Protective Factors; Risk Factors; Diet Healthy; Dietary Supplements; Functional Food; Risk Reduction BehaviorDyslipidemiasPharmacologyLdl cholesterolHealthyEvidence-Based MedicinePrimary preventionCholesterolbusiness.industryFunctional foodFood supplementation functional foods cholesterol LDL-cholesterol cardiovascular risk primary preventionCholesterol LDLProtective FactorsCardiovascular riskDietCardiovascular risk; Cholesterol; Food supplements; Functional foods; LDL cholesterol; Primary prevention; PharmacologyYoung ageCholesterolchemistryCardiovascular DiseasesDietary SupplementsLDL cholesterolPosition paperDiet HealthybusinessRisk Reduction BehaviorBiomarkers
researchProduct